The poll found bipartisan support for allowing Medicare to negotiate drug prices with pharmaceutical companies for its enrollees. While just two out of 10 respondents said drug prices are a major concern to them personally, roughly seven in 10 respondents said they support letting Medicare negotiate prices for all prescription drugs.
However, survey participants did not emphasize any particular proposal to lower drug costs; rather, they indicated the general opinion that some action should be taken. Respondents didn’t give either political party an advantage in this issue, according to the report.
More articles on finance:
CMS confirms good news for Medicare Part B holders in 2016
eScribe purchased by competitor as scribe demand grows in hospitals
Connecticut hospitals launch media campaign against state budget cuts: 6 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.